Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | HTR2C | P28335 | 1/20 | 0.54 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.54 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 6/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TNF | P01375 | 1/20 | 0.37 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.37 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.37 |
| ▸ | CTDSP1 | Q9GZU7 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6991180 | 0.99 | ALDH1A1 (0.52) | ALDH1A1MAPK1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL7632180 | 0.89 | ALDH1A1 (0.51) | ALDH1A1MAPK1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL10588182 | 0.85 | ALDH1A1 (0.54) | ALDH1A1MAPK1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL7989481 | 0.85 | KDM4E (0.54) | ALDH1A1MAPK1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL11408643 | 0.84 | ALDH1A1 (0.52) | ALDH1A1MAPK1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL8504877 | 0.83 | KDM4E (0.46) | ALDH1A1MAPK1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL6991692 | 0.83 | MAPK1 (0.46) | ALDH1A1MAPK1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL5011938 | 0.82 | ALDH1A1 (0.65) | ALDH1A1MAPK1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL6990143 | 0.80 | POLB (0.55) | ALDH1A1MAPK1POLBMAPTTP53 | |
| SCHEMBL8374018 | 0.79 | MAOA (0.42) | ALDH1A1MAPK1KDM4ECYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120052544-A1 | ENUCLEATION OF CELLS WITH PSORALENS | NORTHWESTERN UNIVERSITY | 2012-03-01 | — | — | US | claimed |
| EP-3799868-A1 | PULSE PHOTODYNAMIC TREATMENT OF PHOTODAMAGED SKIN | Galderma Research & Development (FR) | 2021-04-07 | — | — | EP | disclosed |
| EP-3082787-B1 | PULSE PHOTODYNAMIC TREATMENT OF PHOTODAMAGED SKIN | GALDERMA RES & DEV (FR) | 2020-11-25 | — | — | EP | disclosed |
| US-10716855-B2 | Pulse photodynamic treatment of photodamaged skin | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2020-07-21 | — | — | US | disclosed |
| EP-3082788-B1 | PULSE PHOTODYNAMIC TREATMENT OF ACNE | GALDERMA RES & DEV (FR) | 2018-11-21 | — | — | EP | disclosed |
| EP-1176986-B1 | DIFFERENTIATION OF MONOCYTES INTO FUNCTIONAL DENDRITIC CELLS | UNIV YALE (US) | 2018-07-04 | — | — | EP | disclosed |
| EP-3082787-A1 | PULSE PHOTODYNAMIC TREATMENT OF PHOTODAMAGED SKIN | Galderma Research & Development (FR) | 2016-10-26 | — | — | EP | disclosed |
| EP-3082788-A1 | PULSE PHOTODYNAMIC TREATMENT OF ACNE | Galderma Research & Development (FR) | 2016-10-26 | — | — | EP | disclosed |
| US-20160287701-A1 | PULSE PHOTODYNAMIC TREATMENT OF PHOTODAMAGED SKIN | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2016-10-06 | — | — | US | disclosed |
| WO-2015091037-A1 | PULSE PHOTODYNAMIC TREATMENT OF PHOTODAMAGED SKIN | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2015-06-25 | — | — | WO | disclosed |
| US-6455286-B1 | MIXING PSORALEN COMPOUND OF DEFINED STRUCTURE WITH BIOLOGICAL COMPOSITION SUCH AS BLOOD OR PLATELETS, THEN PHOTOACTIVATING COMPOUND TO DEACTIVATE PATHOGEN | CERUS CORPORATION | 2002-09-24 | — | — | US | disclosed |
| EP-1176986-A1 | DIFFERENTIATION OF MONOCYTES INTO FUNCTIONAL DENDRITIC CELLS | Edelson, Richard L. (US) | 2002-02-06 | — | — | EP | disclosed |
| US-20010053355-A1 | Methods for inducing the differentiation of monocytes into functional dendritic cells | YALE UNIVERSITY | 2001-12-20 | — | — | US | disclosed |
| US-6242188-B1 | Sample processing to release nucleic acids for direct detection | APPLIED GENE TECHNOLOGIES, INC. | 2001-06-05 | — | — | US | disclosed |
| EP-1032265-A4 | NEW PSORALENS FOR PATHOGEN INACTIVATION | CERUS CORP (US) | 2001-05-30 | — | — | EP | disclosed |
| WO-2000062818-A1 | DIFFERENTIATION OF MONOCYTES INTO FUNCTIONAL DENDRITIC CELLS | EDELSON RICHARD LESLIE (US) | 2000-10-26 | — | — | WO | disclosed |
| US-6133460-A | HAVE PRIMARY AMINO SUBSTITUTIONS ON THE 3-, 4-, 5-, AND 8-POSITIONS OF THE PSORALEN WHICH PERMIT BINDING TO NUCLEIC ACID OF PATHOGENS; CONDITIONS THAT PHOTOACTIVATE THESE PSORALENS RESULT IN INACTIVATION OF PATHOGENS WHICH CONTAIN NUCLEIC ACID | CERUS CORPORATION (US) | 2000-10-17 | — | — | US | disclosed |
| EP-1032265-A1 | NEW PSORALENS FOR PATHOGEN INACTIVATION | Cerus Corporation (US) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999026476-A1 | NEW PSORALENS FOR PATHOGEN INACTIVATION | CERUS CORPORATION (US) | 1999-06-03 | — | — | WO | disclosed |
| WO-1994020090-A1 | DECONTAMINATING CLINICAL SAMPLES | STERITECH, INC. (US) | 1994-09-15 | — | — | WO | disclosed |